CRVO
CRVO
NASDAQ · Biotechnology

Cervomed Inc

$5.31
+0.71 (+15.43%)
As of Feb 8, 2:18 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +579.5% upside
Low Target $23.71
Average Target $36.08
High Target $52.26
Current Price $5.31
Current
$5.31
Target
$36.08
$23.71 $36.08 avg $52.26
Scenario Analysis
Bear Case
$23.71
346.5%
Low target
Base Case
$36.08
+579.5%
Avg target
Bull Case
$52.26
+884.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$46.89
-88.7% from high
52-Week Low
$20.50
+-74.1% from low
Target vs 52W High
$36.08
-23.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%